Tag - AMGN

Developments

TIAP and Evotec expand LAB150 BRIDGE partnership to Include Amgen

Toronto Innovation Acceleration Partners (TIAP) and Evotec (NASDAQ:EVO; FSE: EVT) have expanded LAB150, their translational BRIDGE partnership, to include Amgen (NASDAQ:AMGN) as a strategic partner. The expansion...

October 17, 2022

Developments

Toronto Innovation Acceleration Partners in pact with Amgen

Toronto Innovation Acceleration Partners (TIAP), formerly MaRS Innovation, and Amgen (NASDAQ:AMGN) are collaborating to jointly fund nascent technologies managed by TIAP on behalf of its Toronto-based member...

September 9, 2019

Executive Moves

Axsome Therapeutics names David Marek as CCO

David Marek Axsome Therapeutics (NASDAQ:AXSM) has appointed David Marek as chief commercial officer, effective Aug. 31. Mr. Marek joins Axsome from Amgen (NASDAQ:AMGN), where he was most recently VP and general manager...

August 20, 2019

Tag - AMGN

TIAP and Evotec expand LAB150 BRIDGE partnership to Include Amgen

Toronto Innovation Acceleration Partners in pact with Amgen

Axsome Therapeutics names David Marek as CCO

General

More